As advised in the news today issued by IVX:
"Further, this opens up partnership possibilities as INV043 may provide potential for
pharmaceutical companies with ICI drugs to improve clinical outcomes, develop new
intellectual property, and extend the patent life of their ICI therapies3.
The global ICI market is estimated to be worth US$29.8 billion in 2020 and is forecast to grow at
a 16.8% compound annual growth rate (CAGR) to US$141 billion by 20301."
Will we see a surge today ? Showing significant strength in the market depth.
Ann: INV043 SIGNIFICANTLY IMPROVED CHECKPOINT INHIBITOR THERAPY, page-4
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
0.003(3.19%) |
Mkt cap ! $8.232M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $3.425K | 34.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5200 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 244080 | 3 |
View Market Depth
| Last trade - 15.55pm 25/07/2025 (20 minute delay) ? |
| IVX (ASX) Chart |